| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |